Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-06-004083
Filing Date
2006-10-16
Accepted
2006-10-16 16:53:53
Documents
9
Period of Report
2006-07-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d69564_10-k.txt 10-K 402593
2 SECURITIES PURCHASE AGREEMENT d69564_ex10-26.txt EX-10.26 48243
3 SUBSIDIARIES OF REGISTRANT d69564_ex21-1.txt EX-21.1 276
4 CONSENT OF INDEPENDENT REG. PUB. ACCT. FIRM #1 d69564_ex23-1.txt EX-23.1 1484
5 CONSENT OF INDEPENDENT REG. PUB. ACCT. FIRM #2 d69564_ex23-2.txt EX-23.2 1847
6 CERTIFICATION (SECTION 302) OF CEO d69564_ex31-1.txt EX-31.1 5266
7 CERTIFICATION (SECTION 302) OF CFO d69564_ex31-2.txt EX-31.2 5213
8 CERTIFICATION (SECTION 906) OF CEO d69564_ex32-1.txt EX-32.1 1829
9 CERTIFICATION (SECTION 906) OF CFO d69564_ex32-2.txt EX-32.2 1892
  Complete submission text file 0001169232-06-004083.txt   470143
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Filer) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-11088 | Film No.: 061146831
SIC: 2836 Biological Products, (No Diagnostic Substances)